Literature DB >> 25402511

A cascade of care for diabetes in the United States: visualizing the gaps.

Mohammed K Ali, Kai McKeever Bullard, Edward W Gregg, Carlos Del Rio.   

Abstract

BACKGROUND: A "cascade-of-care" concept helped to address implementation gaps in HIV care.
OBJECTIVE: To develop a similar cascade for U.S. diabetes care to visualize gaps in awareness of diagnosis, engagement, and treatment.
DESIGN: Nationally representative cross-sectional surveys.
SETTING: 2007 to 2012 NHANES (National Health and Nutrition Examination Surveys). PARTICIPANTS: Nonpregnant civilians aged 18 years or older. MEASUREMENTS: Standardized data collection and laboratory procedures. Diabetes care was benchmarked against recent diabetes and cardiovascular risk reduction guidelines.
RESULTS: In 2012, an estimated 28.4 million (11.8%) U.S. adults had diabetes, of whom 20.5 million (72.2%) were aware of their diagnosis. Among diagnosed adults, 95.3% had a usual care provider and 91.7% made 2 or more visits in the past year. In contrast, among undiagnosed adults, 84.5% had a usual care provider and 66.5% reported 2 or more visits in the past year. Among diagnosed adults, 63.7%, 65.5%, 56.6%, and 80.6% met individualized hemoglobin A1c, blood pressure (BP <140/80 mmHg), lipid (low-density lipoprotein [LDL] cholesterol <2.6 mmol/L [<100 mg/dL]), and nonsmoking goals, respectively; 26.7% met combined ABC (hemoglobin A1c, BP, and LDL cholesterol) targets, and 21.3% met combined ABC targets and did not smoke. Among undiagnosed adults, 77.0%, 57.9%, 36.0%, and 77.9% met hemoglobin A1c, BP, lipid, and nonsmoking goals, respectively; 22.1% met combined ABC targets; and 18.8% met combined ABC targets and were nonsmokers. LIMITATION: Institutionalized and noncivilian persons are not surveyed in NHANES.
CONCLUSION: Three of 10 adults with diabetes remain undiagnosed, which may be related to less access to care. Compared with diagnosed adults, undiagnosed adults have less elevated hemoglobin A1c levels, less lipid treatment and worse control, and similarly poor BP and combined ABC control regardless of smoking status. Addressing these care gaps in both groups would prevent long-term complications. PRIMARY FUNDING SOURCE: None.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25402511     DOI: 10.7326/M14-0019

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  66 in total

1.  Effectiveness of a Multicomponent Quality Improvement Strategy to Improve Achievement of Diabetes Care Goals: A Randomized, Controlled Trial.

Authors:  Mohammed K Ali; Kavita Singh; Dimple Kondal; Raji Devarajan; Shivani A Patel; Roopa Shivashankar; Vamadevan S Ajay; A G Unnikrishnan; V Usha Menon; Premlata K Varthakavi; Vijay Viswanathan; Mala Dharmalingam; Ganapati Bantwal; Rakesh Kumar Sahay; Muhammad Qamar Masood; Rajesh Khadgawat; Ankush Desai; Bipin Sethi; Dorairaj Prabhakaran; K M Venkat Narayan; Nikhil Tandon
Journal:  Ann Intern Med       Date:  2016-07-12       Impact factor: 25.391

Review 2.  Genetics of diabetic nephropathy: a long road of discovery.

Authors:  Amy Jayne McKnight; Seamus Duffy; Alexander P Maxwell
Journal:  Curr Diab Rep       Date:  2015-07       Impact factor: 4.810

3.  Development of a Cascade of Care for responding to the opioid epidemic.

Authors:  Arthur Robin Williams; Edward V Nunes; Adam Bisaga; Frances R Levin; Mark Olfson
Journal:  Am J Drug Alcohol Abuse       Date:  2019-01-24       Impact factor: 3.829

4.  Adopting the 'cascade of care' framework: an opportunity to close the implementation gap in addiction care?

Authors:  M Eugenia Socías; Nora Volkow; Evan Wood
Journal:  Addiction       Date:  2016-07-13       Impact factor: 6.526

5.  Current Consensus and Controversies in Guidelines for Lipid and Hypertension Management in Diabetes.

Authors:  Om P Ganda; Joanna Mitri
Journal:  Curr Cardiol Rep       Date:  2016-11       Impact factor: 2.931

Review 6.  Impact of HbA1c Testing at Point of Care on Diabetes Management.

Authors:  Oliver Schnell; J Benjamin Crocker; Jianping Weng
Journal:  J Diabetes Sci Technol       Date:  2016-11-27

7.  Use of the PRECIS-II instrument to categorize reports along the efficacy-effectiveness spectrum in an hepatitis C virus care continuum systematic review and meta-analysis.

Authors:  Ashly E Jordan; David C Perlman; Daniel J Smith; Jennifer R Reed; Holly Hagan
Journal:  J Clin Epidemiol       Date:  2017-11-02       Impact factor: 6.437

8.  Awareness and access to naloxone necessary but not sufficient: Examining gaps in the naloxone cascade.

Authors:  Karin Tobin; Catie Clyde; Melissa Davey-Rothwell; Carl Latkin
Journal:  Int J Drug Policy       Date:  2018-07-31

Review 9.  Advancing Health Policy and Program Research in Diabetes: Findings from the Natural Experiments for Translation in Diabetes (NEXT-D) Network.

Authors:  Mohammed K Ali; Frank Wharam; O Kenrik Duru; Julie Schmittdiel; Ronald T Ackermann; Jeanine Albu; Dennis Ross-Degnan; Christine M Hunter; Carol Mangione; Edward W Gregg
Journal:  Curr Diab Rep       Date:  2018-11-20       Impact factor: 4.810

10.  Translating What Works: A New Approach to Improve Diabetes Management.

Authors:  Lawrence S Phillips; Diana Barb; Chun Yong; Anne M Tomolo; Sandra L Jackson; Darin E Olson; Mary K Rhee; Ingrid M Duva; Qing He; Qi Long
Journal:  J Diabetes Sci Technol       Date:  2015-03-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.